Biochemistry of the menopause
Author:
Open Access
- 2 November 2017
- journal article
- review article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 55 (1) , 18-33
Abstract
The life of a human female is characterized from teenage years by monthly menstruation which ceases (the menopause) typically between the age of 40 and 60 years. The potential for reproduction declines and ceases as the ovaries become depleted of follicles. A transition period in mid-life, for 2 to 10 years, when menstruation is less regular is called the perimenopause. The menopause is associated with a significant decline in plasma concentrations of sex hormones, an increase in the concentrations of the gonadotrophins and changes in other hormones such as the inhibins. These changes are superimposed with effects of aging, social and metabolic factors, daily activity and well-being. Although the menopause is entirely natural, in some cases ovarian failure can occur earlier than usual; this is pathological and warrants careful biochemical investigations to distinguish it from conditions causing infertility. Elderly females are affected by a range of clinical disorders including endocrine, cardiovascular, skeletal, urogenital tract and immunological systems, body mass, vasomotor tone, mood and sleep pattern. Reference intervals for many diagnostic biochemical tests for the menopause need to be used when interpreting results in clinical investigations for patient management. The standardization and harmonization of assays are being addressed. Many women now choose to develop their career before bearing children, and the health service has had to change services around this. This review does not cover screening for and tests during pregnancy. The review is timely since the population is aging and there will be more demand on healthcare services.Keywords
This publication has 183 references indexed in Scilit:
- Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patientsSpringerPlus, 2013
- Progesterone receptors, their isoforms and progesterone regulated transcriptionMolecular and Cellular Endocrinology, 2012
- Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?Journal of Lipids, 2012
- The levels of bone turnover markers in Chinese postmenopausal womenMenopause, 2011
- Reproductive Hormones and the Menopause TransitionObstetrics and Gynecology Clinics of North America, 2011
- The Timing of the Age at Which Natural Menopause OccursObstetrics and Gynecology Clinics of North America, 2011
- Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography–tandem mass spectrometrySteroids, 2011
- Gender specificity of altered human immune cytokine profiles in agingThe FASEB Journal, 2010
- Estrogen–Growth Factor Interactions and Their Contributions to Neurological DisordersHeadache: The Journal of Head and Face Pain, 2008
- Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate Target Genes with Estrogen Receptors α and βMolecular Biology of the Cell, 2004